Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=lgndLatest Financial News for Ligand Pharmaceuticals Incorporen-usThu, 24 Dec 2009 11:04:37 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091224/lgnd8-k.htmlyahoo_finance/1137604111Thu, 24 Dec 2009 11:04:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091223/20091223005573.html?.v=1SAN DIEGO----Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation , following approval of the transaction by Neurogen stockholders earlier today.yahoo_finance/2143220139Wed, 23 Dec 2009 22:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091221/lgnd8-k.htmlyahoo_finance/1461585432Mon, 21 Dec 2009 17:02:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091218/us_ligand_pharmaceuticals_product.html?.v=1Ligand Pharmaceuticals Inc. said Friday a European advisory committee recommended approval of the blood disorder treatment Revolade.yahoo_finance/3631314999Fri, 18 Dec 2009 15:24:31 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091218/20091218005307.html?.v=1SAN DIEGO----Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® from the European Medicines Agency’s Committee for Medicinal Products for Human Use for the oral treatment of thrombocytopenia in adults with the blood disorder chronic immune thrombocytopenic purpura .yahoo_finance/169449628Fri, 18 Dec 2009 14:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh29572_2009-12-18_12-43-09_lde5bg286_newsml&rpc=44&type=marketsNewsyahoo_finance/3201720788Fri, 18 Dec 2009 12:43:09 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_ligand_neurogen_acquisition.html?.v=1Ligand Pharmaceuticals Inc. said Thursday it amended a deal to buy Neurogen Corp., adding $600,000 in cash to stockholders.yahoo_finance/1480597839Thu, 17 Dec 2009 21:16:53 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091217/lgnd8-k.htmlyahoo_finance/2754879905Thu, 17 Dec 2009 17:32:29 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217005969.html?.v=1SAN DIEGO & BRANFORD, Conn.----Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced today they have amended their merger agreement to increase the merger consideration payable.yahoo_finance/962673216Thu, 17 Dec 2009 17:32:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12uskq525/*http%3A//www.fool.com/investing/general/2009/12/16/7-stocks-losing-top-investor-support.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2377009374Wed, 16 Dec 2009 17:22:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/lgnd8-k.htmlyahoo_finance/2786103959Tue, 15 Dec 2009 19:52:50 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091201/lgnd8-k.htmlyahoo_finance/3442135310Tue, 1 Dec 2009 21:54:24 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12mpk2d11/*http%3A//www.fool.com/investing/general/2009/11/25/4-star-stocks-on-the-upswing.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3377332149Wed, 25 Nov 2009 19:42:46 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091124/lgnd8-k.htmlyahoo_finance/1904382002Tue, 24 Nov 2009 18:49:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12khd1gf9/*http%3A//www.fool.com/investing/general/2009/11/23/5-top-stocks-at-half-price.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3801686777Mon, 23 Nov 2009 17:25:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091123/lgnd8-k.htmlyahoo_finance/3185831903Mon, 23 Nov 2009 17:07:51 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091120/20091120005103.html?.v=1SAN DIEGO----Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta.yahoo_finance/3489789050Fri, 20 Nov 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091119/lgnd8-k.htmlyahoo_finance/2228881986Thu, 19 Nov 2009 20:33:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091119/us_ligand_pharmaceuticals_contract.html?.v=2Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co. as part of a research collaboration.yahoo_finance/3145831469Thu, 19 Nov 2009 18:23:22 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091119/20091119005539.html?.v=1SAN DIEGO----Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.yahoo_finance/217504357Thu, 19 Nov 2009 13:30:00 Etc/GMT